Aclarion Participated In The International Society Of Pain And Neuroscience Annual Meeting, Announces Use Of MR Spectroscopy For Identifying Biomarkers Of Discogenic Pain
Benzinga Newsdesk 1 year ago
NewsHealth CareGeneral
Aclarion's Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians differentiate between painful and non-painful discs in the lumbar spine. Nociscan converts MR spectroscopy
Aclarion's Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians differentiate between painful and non-painful discs in the lumbar spine. Nociscan converts MR spectroscopy signals into objective biomarkers demonstrated to be associated with disc pain. This provides actionable information that enables physicians to develop more personalized treatment plans for patients.